Description
Tadaga power (Tadalafil) 80 mg
Tadaga power is presented as a tadalafil tablet. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor. The verified medical information for tadalafil supports its use in erectile dysfunction, and in some approved products also in benign prostatic hyperplasia-related lower urinary tract symptoms and pulmonary arterial hypertension, depending on the formulation and authorisation.
Active Ingredient and Medicine Class
Active ingredient: tadalafil.
Medicine class: phosphodiesterase type 5 (PDE5) inhibitor. This class reduces the breakdown of cyclic guanosine monophosphate (cGMP), helping relax smooth muscle in blood vessels and certain tissues.
Established Medical Uses
Tadalafil is established for the treatment of erectile dysfunction. Regulatory information also supports tadalafil-containing medicines for pulmonary arterial hypertension, and some tadalafil products are approved for benign prostatic hyperplasia-associated urinary symptoms. The exact approved use depends on the specific product and jurisdiction.
How It Works
Tadalafil blocks PDE5, an enzyme involved in the breakdown of cGMP. By preserving cGMP activity, it supports smooth-muscle relaxation and increased blood flow in response to sexual stimulation. Reviews of tadalafil also note its relatively long duration of action compared with other PDE5 inhibitors.
Important Safety Information
Tadalafil is contraindicated with organic nitrates because of the risk of marked hypotension. Regulatory information also warns about additive blood-pressure-lowering effects with alpha-blockers and with alcohol. Tadalafil should not be used with other PDE5 inhibitors. Product information for tadalafil-containing medicines also includes precautions in patients with cardiovascular disease and other conditions where sexual activity may pose risk.
Possible Side Effects
Common adverse effects reported with tadalafil include headache, dyspepsia, back pain, muscle pain, flushing and nasal congestion. Serious reactions can include severe low blood pressure, prolonged erection, sudden vision loss, and sudden hearing decrease or loss.
Scientific Evidence
PubMed-indexed reviews and clinical analyses report that tadalafil improves erectile function in a broad range of patients and that its long duration of action may support flexible use. Evidence also supports benefit in lower urinary tract symptoms associated with benign prostatic hyperplasia for approved doses and indications.
Medical Information Notice
This educational summary is based on sources available at the time of review and does not replace the official patient leaflet, prescribing information, or individual assessment by a qualified healthcare professional.
Medical Sources
- FDA — CIALIS (tadalafil) tablets, for oral use: Prescribing Information
- Meuleman EJ. “Review of tadalafil in the treatment of erectile dysfunction.” PubMed article
